From the Children's Hospital Research Foundation and the Department of Pediatrics, University of Cincinnati College of Medicine. Supported in part by a grant (RG-7837) from the National Institutes ...

S-64315 is under clinical development by Les Laboratoires Servier and currently in Phase II for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia). According to GlobalData, Phase II drugs ...

UltraCAR-T is under clinical development by SaxoCell and currently in Phase II for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia). According to GlobalData, Phase II drugs for Acute ...

SURVIVAL in myeloblastic leukemia of adults has not appreciably changed since the advent of chemotherapy. As pointed out by Gunz et al., 1 the progress of the disease may be quite variable ...

This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Chronic subdural hematoma, a common neurosurgical disease, is mostly caused by craniocerebral trauma. Chronic subdural hematoma caused by acute myeloblastic leukemia is rarely reported, and its ...

Acute myeloblastic leukemia (AML) is another name for acute myeloid leukemia. AML refers to a group of cancers of the blood and the bone marrow. AML, which medical experts also call acute myeloid ...

1 Department of Haematology & HSCT, Evercare Hospital, Dhaka, Bangladesh. 2 Department of Haematology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. 3 Department of Physiology, ...

Performing a blood screening. A single-center retrospective study assessed the effectiveness of serum albumin levels and BMI as prognostic measures in patients with AML. Serum albumin (SA) levels ...